Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nereo Segnan

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytologyGuglielmo Ronco, Jack Cuzick, Nereo Segnan, et al.
Journal of the National Cancer Institute|March 28, 2008
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening testGuglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
Epidemiologia E Prevenzione|January 8, 2013
[Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity]Guglielmo Ronco, Pamela Giubilato, Carlo Naldoni, et al.
Journal of the National Cancer Institute|June 8, 2006
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trialGuglielmo Ronco, Nereo Segnan, Paolo Giorgi-Rossi, et al.
Epidemiologia E Prevenzione|August 30, 2006
Audit system on Quality of breast cancer diagnosis and Treatment (QT): results from the survey on screen-detected lesions in Italy, 2003-2004Antonio Ponti, Maria Piera Mano, Vito Distante, et al.
The Lancet. Oncology|September 12, 2008
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trialFrancesca Carozzi, Massimo Confortini, Paolo Dalla Palma, et al.
BMC Infectious Diseases|May 28, 2013
Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trialIacopo Baussano, Silvia Franceschi, Anna Gillio-Tos, et al.
Annals of Internal Medicine|November 8, 2021
Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening TrialCarlo Senore, Emilia Riggi, Paola Armaroli, et al.
Health Policy (Amsterdam, Netherlands)|September 2, 2018
Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countriesEleanor Turnbull, Jennifer Priaulx, Inge M C M de Kok, et al.
BMC Health Services Research|January 29, 2013
Compliance with clinical practice guidelines for breast cancer treatment: a population-based study of quality-of-care indicators in ItalyCarlotta Sacerdote, Rita Bordon, Sabina Pitarella, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytologyGuglielmo Ronco, Jack Cuzick, Nereo Segnan, et al.
Journal of the National Cancer Institute|March 28, 2008
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening testGuglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
Epidemiologia E Prevenzione|January 8, 2013
[Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity]Guglielmo Ronco, Pamela Giubilato, Carlo Naldoni, et al.
Journal of the National Cancer Institute|June 8, 2006
Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trialGuglielmo Ronco, Nereo Segnan, Paolo Giorgi-Rossi, et al.
Epidemiologia E Prevenzione|August 30, 2006
Audit system on Quality of breast cancer diagnosis and Treatment (QT): results from the survey on screen-detected lesions in Italy, 2003-2004Antonio Ponti, Maria Piera Mano, Vito Distante, et al.
The Lancet. Oncology|September 12, 2008
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trialFrancesca Carozzi, Massimo Confortini, Paolo Dalla Palma, et al.
BMC Infectious Diseases|May 28, 2013
Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trialIacopo Baussano, Silvia Franceschi, Anna Gillio-Tos, et al.
Annals of Internal Medicine|November 8, 2021
Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening TrialCarlo Senore, Emilia Riggi, Paola Armaroli, et al.
Health Policy (Amsterdam, Netherlands)|September 2, 2018
Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countriesEleanor Turnbull, Jennifer Priaulx, Inge M C M de Kok, et al.
BMC Health Services Research|January 29, 2013
Compliance with clinical practice guidelines for breast cancer treatment: a population-based study of quality-of-care indicators in ItalyCarlotta Sacerdote, Rita Bordon, Sabina Pitarella, et al.
Pageof 18